K2 Principal Fund’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

K2 Principal Fund’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-208,608	Closed	-$4.36M	–	391
2016 Q3	$4.36M	Buy	+208,608	New	+$2.4M	0.49%	59

K2 Principal Fund's VTAE Position: Q4 2016 in Review

K2 Principal Fund sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 208,608 shares — an estimated $4.36M sold.

K2 Principal Fund first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $4.36M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

K2 Principal Fund reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
K2 Principal Fund sold 208,608 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $4.36M.
K2 Principal Fund first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
K2 Principal Fund's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $4.36M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on K2 Principal Fund's 13F filing for Q4 2016, filed 15 Feb 2017.